Results of BOD Meeting

The Board approved a new long-term growth strategy focused on disciplined capital allocation, organic expansion, and selective acquisitions within the healthcare and education sectors.
Approval was granted to provide up to AED 70 million in funding to Cambridge Health Group, a wholly-owned subsidiary, to develop the Al Malaz Project in Riyadh, Saudi Arabia.
A three-year dividend policy was established, targeting a minimum annual cash dividend of 7 fils per share (7% yield on issued capital), payable on a semi-annual basis subject to regulatory requirements.